Sage Journals: Discover world-class research

Retricted access

Research article

First published 2000-05

Improved Gene Transfer to Neuroblastoma Cells by a Monoclonal Antibody Targeting RET,a Receptor Tyrosine Kinase

Lisa Yano, Mari Shimura, Mika Taniguchi [...]

Human Gene Therapy

Retricted access

Research article

First published 2023-10-10

Structure-Based Identification of Natural Compounds as Potential RET-Kinase Inhibitors for Therapeutic Targeting of Neurodegenerative Diseases

Gulam Mustafa Hasan, Anas Shamsi, Sukhwinder Singh Sohal [...]

Journal of Alzheimer’s Disease

Open access

Research article

First published 2020

Novel RET agonist for the treatment of experimental neuropathies

Hanna Viisanen, Ulpukka Nuotio, Oleg Kambur [...]

Molecular Pain

Open access

Research article

First published 2021

Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats

Juho-Matti Renko, Arun Kumar Mahato, Tanel Visnapuu [...]

Journal of Parkinson’s Disease

Retricted access

Other

First published 2003-9

RET/PTC Oncoproteins: Molecular Targets of New Drugs

Cinzia Lanzi, Giuliana Cassinelli, Giuditta Cuccuru [...]

Tumori Journal

Retricted access

Research article

First published 2006-12

Comparison of Different Strategies to Select Aptamers Against a Transmembrane Protein Target

Carine Pestourie, Laura Cerchia, Karine Gombert [...]

Nucleic Acid Therapeutics

Open access

Review article

First published 2023

Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China

Tao Li, Wen-Yu Yang, Ting-Ting Liu [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2021-10

Differential receptor tyrosine kinase phosphorylation in the uterus of rats following developmental exposure to tetrabromobisphenol A

Lysandra Castro, Jingli Liu, Linda Yu [...]

Toxicology Research and Application

Open access

Review article

First published 2020

Current management of RET rearranged non-small cell lung cancer

Thomas E Stinchcombe

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2013-12

In Vitro and In Vivo Activity of Cabozantinib (XL184),an Inhibitor of RET,MET,and VEGFR2,in a Model of Medullary Thyroid Cancer

Frauke Bentzien, Marcus Zuzow, Nathan Heald [...]

Thyroid®

Search results